Australija - anglų - Department of Health (Therapeutic Goods Administration)

diasorin australia pty ltd - ct780 - brucella ivds - for in vitro diagnostic use in testing clinical specimens for antibodies to brucella bacteria.

Australija - anglų - Department of Health (Therapeutic Goods Administration)

abacus dx pty ltd - ct780 - brucella ivds - to be used in testing to provide information about infection with or exposure to brucella bacteria.

Australija - anglų - Department of Health (Therapeutic Goods Administration)

esl biosciences australia 2012 pty ltd - ct780 - brucella ivds - ivds that are intended to be used in testing to provide information about infection with or exposure to brucella bacteria.

Australija - anglų - Department of Health (Therapeutic Goods Administration)

biomerieux australia pty ltd - ct780 - brucella ivds - ivds intended to be used in testing to provide information about infection with or exposure to brucella bacteria.

Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

deseret biologicals, inc. - brucella melitensis (unii: oqf85710lz) (brucella melitensis - unii:oqf85710lz) - brucella melitensis - fever, sweats, malaise, headache, back pain, neck pain, malodorous sweat, gut inflammation • for the temporary relief of symptoms including: • fever • sweats • malaise • headache • back pain • neck pain • malodorous sweat • gut inflammation these statements are based upon homeopathic principles. they have not been reviewed by the food and drug administration.

Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

liberty pharmaceuticals, inc. - doxycycline hyclate (unii: 19xts3t51u) (doxycycline anhydrous - unii:334895s862) - doxycycline anhydrous 100 mg - to reduce the development of drug-resistant bacteria and maintain effectiveness of doxycycline hyclate and other antibacterial drugs, doxycycline hyclate should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. doxycycline is indicated for the treatment of the following infections: -  rocky mountain spotted fever, typhus fever and the typhus group, q. fever, rickettsialpox, and tick fevers caused by rickettsiae. -  respiratory tract infections caused by mycoplasma pneumoniae. -  lymphogranuloma venereum caused by chlamydia trachomatis. -  psittacosis (ornithosis) caused by chlamydia psittaci. -  trachoma caused by chlamydia trachomatis, although the infectious agent is not always el

Australija - anglų - Department of Health (Therapeutic Goods Administration)

dksh australia pty ltd - ct780 - brucella ivds - immunserological in vitro diagnostic medical devices to be used in infectious disease diagnostics.

Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

chartwell governmental & specialty rx llc - doxycycline hyclate (unii: 19xts3t51u) (doxycycline anhydrous - unii:334895s862) - doxycycline anhydrous 100 mg

Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

the wellness center for research and education - horseradish (unii: 8ds6g120hj) (horseradish - unii:8ds6g120hj), taraxacum officinale (unii: 39981fm375) (taraxacum officinale - unii:39981fm375), tabebuia impetiginosa bark (unii: 6gla1946wx) (tabebuia impetiginosa bark - unii:6gla1946wx), brucella abortus (unii: 492lcm0tul) (brucella abortus - unii:492lcm0tul), escherichia coli (unii: 514b9k0l10) (escherichia coli - unii:514b9k0l10), germanium (unii: 00072j7xws) (germanium - unii:00072j7xws), human sputum, bordetella pertussis infected (unii: u364v64 - horseradish 3 [hp_x] in 1 ml - chronic fatigue, rash, flu-like symptoms, swelling and joint pain (like arthritis), tingling and numbness in your hands, feet and back, brain fog, poor memory, weakness or paralysis in your face muscles. chronic fatigue, rash, flu-like symptoms, swelling and joint pain (like arthritis), tingling and numbness in your hands, feet and back, brain fog, poor memory, weakness or paralysis in your face muscles.

Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

felix pharmaceuticals private limited - enrofloxacin (unii: 3dx3xek1bn) (enrofloxacin - unii:3dx3xek1bn) - enrofloxacin flavored tablets are indicated for the management of diseases associated with bacteria susceptible to enrofloxacin. enrofloxacin flavored tablets are indicated for use in dogs and cats. enrofloxacin is contraindicated in dogs and cats known to be hypersensitive to quinolones. dogs: based on the studies discussed under the section on animal safety summary, the use of enrofloxacin is contraindicated in small and medium breeds of dogs during the rapid growth phase (between 2 and 8 months of age). the safe use of enrofloxacin has not been established in large and giant breeds during the rapid growth phase. large breeds may be in this phase for up to one year of age and the giant breeds for up to 18 months. in clinical field trials utilizing a daily oral dose of 5.0 mg/kg, there were no reports of lameness or joint problems in any breed. however, controlled studies with histological examination of the articular cartilage have not been conducted in the large or giant breeds.